Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries

Armando Arredondo · Alexis Zúñiga

108 citations0/0 files storedDiabetes Care

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Health Systems, Economic Evaluations, Quality of Life Healthcare Systems and Reforms Global Health Care Issues

Abstract

OBJECTIVE: To identify the costs and economic consequences of expected changes in the demand for health care services for type 2 diabetes in the three main public institutions of the Mexican health care system. RESEARCH DESIGN AND METHODS: The cost evaluation method to estimate direct and indirect costs was based on instrumentation and consensus techniques. To estimate the costs and epidemiological changes for 2003-2005, three probabilistic models were constructed according to the Box-Jenkins technique. RESULTS: Comparing the economic impact in 2003 versus 2005 (P < 0.05), there is a 26% increase in financial requirements. The total amount for diabetes in 2005 (in U.S. dollars) will be 317,631,206, dollars including 140,410,816 dollars in direct costs and 177,220,390 dollars in indirect costs. The total direct costs, representing financial requirements to provide health care for expected cases of type 2 diabetes and its main complications in the three main public institutions in Mexico, up to 2005, will be 37,079,587 dollars for the Ministry of Health (or Secretaría de Salud [SSA], serving the uninsured population) and 103,331,235 dollars for the Mexican Social Security Institute, or Instituto Mexicano del Seguro Social (IMSS), and the Institute for Social Security and Services for State Workers, or Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), both of which serve the insured population. CONCLUSIONS: Our data suggest that changes in the demand for health care services for patients with diabetes will continue with an increasing trend, mainly in the insured population. In economic terms, the results of direct and indirect costs are one of the main challenges to be solved to decrease the economic burden that diabetes represents for the population, the health care institutions, and for society as a whole.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 108 citations exist upstream.

References

2003Economic Costs of Diabetes in the U.S. in 2002 1998Economic Consequences of Diabetes Mellitus in the U.S. in 1997 2003The cost of diabetes in Latin America and the Caribbean.1989The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus 2001Equity and the economic evaluation of healthcare 1998The Effects of Treatment on the Direct Costs of Diabetes 2002The Economic Cost of Diabetes in Canada, 1998

Cited by

2005Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico 2014Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine 2005Childhood predictors of late‐life diabetes: The case of Mexico 2012Diabetes: A Global Challenge With High Economic Burden for Public Health Systems and Society 2007The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.